Ignite Creation Date:
2025-12-26 @ 2:40 PM
Ignite Modification Date:
2025-12-30 @ 1:47 PM
Study NCT ID:
NCT04813406
Status:
UNKNOWN
Last Update Posted:
2021-03-24
First Post:
2021-03-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Anlotinib Plus Sintilimab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
Sponsor:
Henan Provincial People's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2020-115-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None